Navigation Links
IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients
Date:11/2/2007

- Patients on IDM-2101 showed an improvement in median survival vs.

parallel external controls -

IRVINE, Calif., Nov. 2 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI) today announced updated results from the Phase 2 study of its investigational agent IDM-2101 which showed the vaccine was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in patients with non-small cell lung cancer (NSCLC) who were vaccinated with IDM-2101, compared to a parallel external control group of non-vaccinated patients.

The data will be presented during an oral session on Sunday, November 4 at 8:45 a.m. EST at the International Society for Biological Therapy of Cancer (iSBTc) annual meeting in Boston.

"We are encouraged by the positive trend in overall survival we are seeing in patients who were treated with IDM-2101," said Minal Barve, M.D., practice director, Mary Crowley Cancer Research Center. "We believe that the survival trend, as well as the tolerability and robust immunological response data, warrant further examination to confirm the treatment benefits of IDM-2101 for patients with non-small cell lung cancer."

Trial Design and Results

The Phase 2 open label, non-randomized trial with one year follow-up for survival was designed to assess overall survival and vaccine immunogenicity in HLA-A2 positive patients with stage IIIb, IV or recurrent non-small cell lung cancer. Patients were required to have tumor volume less than 125 cm squared with no limits on prior chemotherapy. Sixty-eight patients were enrolled in the trial (sixty-three treated with one or more doses) with the last patient enrolled in Mar
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Ranbaxy Laboratories Limited ... Ltd. (hereafter, Daiichi Sankyo), announced on May 22 ... years to address past conduct under prior management ... Daiichi Sankyo continues to support Ranbaxy in ... of the past which led to the investigations ...
(Date:5/22/2013)... Israel , May 22, 2013  Rosetta Genomics ... and provider of microRNA-based molecular diagnostics, announces that ... Executive Officer of Rosetta Genomics, will deliver a corporate ... from June 3-6, 2013 in New York City.  Mr. ... th at 2:00 p.m. Eastern time. ...
(Date:5/22/2013)... 22, 2013  BD (Becton, Dickinson and Company) (NYSE: ... company, announced today the publication of its 2012 ... and it continues to focus on the Company,s shared ... the principles of shared value — creating value for ... societies — are fundamental to our strategy," said ...
Breaking Medicine Technology:Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3
(Date:5/22/2013)... 2013 The newest member of TeethWhiteningforFree.com ... University of Alabama graduate, Dr. Sanderson provides professional dental ... TeethWhiteningforFree.com dentist, he extends complimentary teeth whitening to his ... and/or check up. Only a dental professional can decide ... whitening treatments. , Teeth whitening is an ...
(Date:5/22/2013)... John Theurer Cancer Center at Hackensack University Medical Center, ... bring together leading cancer experts, for presentation and discussion ... and interventional immunology in oncology, on Friday, June 7 ... bring together some of the nation,s top immunology experts ... therapies in oncology, both in solid and liquid tumors," ...
(Date:5/22/2013)... 2013 Spinal Elements, an innovative ... in Carlsbad to 3115 Melrose Drive, Suite 200, ... company’s continued and projected growth and has expanded ... feet to over 40,000 square feet. , ... indicated, “Our investment in these state-of-the-art facilities will ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The ... Rensselaer Polytechnic Institute today announced an affiliation agreement ... of new diagnostic tools and treatments that promote ... signing ceremony on May 22, 2013. , The ... in engineering and invention prototyping and Mount Sinai’s ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Many problems can ... deal of pain for a patient if left untreated. ... pain could be easily fixed through occlusal adjustment. A ... neck and back pain should have their dentist check their ... the bite and can lead to problems if the bite ...
Breaking Medicine News(10 mins):Health News:Dr. James Sanderson, Jr. Of SanDentistry in Hoover, Alabama Joins the TeethWhiteningforFree.com Family 2Health News:Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies 2Health News:Spinal Elements®, Inc. Relocates Corporate Headquarters in Carlsbad 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 3Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 4Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 5Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 6Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 7Health News:Dr. Martin N. Gorman: Make Headaches, Sensitive Teeth and Neck or Back Pain a Thing of the Past 2
... 17 LifeNet Health, a leading,biomedical and allograft ... Wound Allograft Institute" in affiliation with The Living ... and most progressive,organ and tissue recovery organizations in ... Institute" will directly serve the needs of burn,patients ...
... This release is available in French . ... use maps, satellite images, and other location-based or geospatial ... of Canada,s most pressing challenges, including public health. Through ... promoting this merger of geomatics with public health because ...
... 17 Fauquier Health,System of Warrenton, Virginia announces ... service professionals are all too familiar with,traveling to ... in the hopes of winning a sale. Vernon ... apply the health sytem,s long-standing,commitment to individualized patient ...
... quarters for St. Margaret,s Daughters, Home, NEW ORLEANS, ... Home in New Orleans will be reunited in a,temporary ... the wake,of Hurricane Katrina. The 116-bed eldercare facility ... the city,s Ninth Ward. While everyone at St.,Margaret,s was ...
... able to detect and treat Alzheimers Disease (AD) in ... degrees of cognitive impairment, thanks to new diagnostic criteria ... Lancet Neurology, the development of new guidelines was co-led ... Neurology in the University of British Columbias Faculty of ...
... of the 62nd United Nations General Assembly Tomorrow, September ... ... dying,of hunger every day and governments failing to meet their millennium,commitment to halve ... and hunger to play a,central role "on the table" of the 62nd United ...
Cached Medicine News:Health News:LifeNet Health Establishes 'The Skin & Wound Allograft Institute' 2Health News:Canada's government funds $1.6M in modern geography to support public health decisions 2Health News:Fauquier Health System Holds a Food Show with a Twist Long Term Care Patients Hold the Judge's Pen as Vendors Vie for Approval 2Health News:Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff 2Health News:Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff 3Health News:New way to diagnose Alzheimer's disease promises earlier treatment 2Health News:HungerFREE Campaign Tells UN: 'Put food on the table' 2
Corneal Marker - 8 blades, 2 sizes available: 7.0mm, 8.0mm. 1 piece per box...
... A new generation in automated semen analysis, ... push of a button. Automation provides standardization ... subjectivity out of semen analysis. SPERMALITE is ... parameters for remote semen analysis, and a ...
Stainless Steel. Sterile. 2 pieces/box...
... 4.5/5.0 mm Cannulated Screw System ... of modular systems developed by ... ranging from 3.5mm to 8.0mm. ... screws, the system was designed ...
Medicine Products: